A rat Proteus and Escherichia pyelonephritis model is described in which (i) reproducible chronic infections are achieved and (ii) the efficacy of clinically effective agents is reliably demonstrable with five rats in 17 days. It can serve as a primary screen in which one technician can evaluate 180 compounds per month with 900 rats. The manner of inoculation will inherently allow the study of and distinction between metabolism which is peculiar to infection and that which is characteristic of trauma and healing in general for the elucidation of chemical correlations with effective therapy.
A rat Proteus and Escherichia pyelonephritis model is described in which (i) reproducible chronic infections are achieved and (ii) the efficacy of clinically effective agents is reliably demonstrable with five rats in 17 days. It can serve as a primary screen in which one technician can evaluate 180 compounds per month with 900 rats. The manner of inoculation will inherently allow the study of and distinction between metabolism which is peculiar to infection and that which is characteristic of trauma and healing in general for the elucidation of chemical correlations with effective therapy.
Given the task of developing an effective in vivo antimicrobial screen for the most serious urinary tract infections-the pyelonephritides-it was decided that what was required in our situation was a small animal, primary/secondary screening model capable of evaluating large numbers of compounds. It was further decided that such a model would initially be satisfactory for discovery of leads if it met only two criteria. (i) The efficient infection of the kidney should be reasonably reproducible and preferably limited to this organ; and (ii) most clinically effective drug products should produce, by some simple regimen, significant reduction in the number of viable organisms in the infected areas.
MATERIALS AND METHODS
CFN rats of either sex housed five per wire mesh cage [15 by 14 by 7 inches (38 by 35 by 18 cm)] and weighing 160 to 184 g were anesthetized with ether and inoculated with a saline suspension of a 16-hr Brain Heart Broth culture of Escherichia coli or Proteus mirabilis. The suspension was introduced to the cortex of the kidney by means of a 0.25-inch (0.63 cm), 27 gauge needle attached to a 0.5-ml syringe. Entrance to the abdominal cavity and left kidney was gained by a quick jab of the needle. The area to be entered was first rinsed with disinfectant and the kidney was positioned immediately beneath the skin of the rat and between the thumb and forefinger of the operator. After the needle had penetrated the kidney, slight pressure was maintained on the kidney briefly and then released prior to puncturing the kidney three or four additional times without pressure on the plunger and without removing the needle from the abdomen. Routinely, only the left kidney was infected experimentally.
Kidneys were prepared for determination of their content of viable bacteria by excising them from the ether-anesthetized rat and then teasing away the pelvis The organs were then rinsed in a stream of sterile saline and subsequently immersed in the saline in which they were finally ground in a glass homogenizer. Removing the pelvis minimized the influence any bacteriuria might have on the viable count-per-gram parameter, while excluding from the titration only a very small amount of tissue which ordinarily would be included in a rigorous examination of an infected kidney. Viable titer was determined either by brain heart agar plate counts of appropriate saline dilutions of the kidney brei or by dilution end point of the brei in brain heart broth by use of an Aminco automatic diluter, plastic cup disposable trays [8 by 12 inches (20 by 30 cm)], and 12 fivefold dilution steps starting with a 1:30 or 1:100 saline suspension of the homogenized kidney. Assays of viable bacteria in other tissues were performed similarly. The automatic diluter was acquired during the course of this work and has subsequently been used routinely for all primary analyses. After acquiring the automatic diluter, plate counts were made routinely only on reevaluation of an active compound or when some other purpose dictated, as in evaluating the incidence and nature of drug-resistant organisms at various times during therapy. The viable titers were expressed as the log1o of the geometric mean of the viable titers of five kidneys-often called "log average" for brevity. RESULTS
Titers of viable organisms in infected kidneys. Groups of 100 to 200 rats were infected on the same day, and 5 or 10 animals were sacrificed for observation at times ranging from immediately after infection to 5 weeks after infection. Clinical isolates from human Proteus and Escherichia urinary tract infections were used. A number of strains of each organism were tested. Some strains were fatal to the majority of rats infected within a Table 2 shows some typical viable titers observed in E. coli Es-90 infections at the end of the 14-day, twice daily regimen with a number of compounds. Some typical viable titers observed in P. mirabilis infections at the end of the 14-day, twice daily regimen with a number of compounds are given in Table 3 .
Viable organisms in other tissues. In these models infections are rarely found in tissues other than the urinary tract. When the work on these models was started, tests were routinely made on homogenates of spleen, liver, lungs, and contralateral (not experimentally infected) kidneys. The incidence of infection was nil, except for the experimentally uninfected kidneys, which became infected about once per 400 or 500 rats. Only occasional spot checks have been made since these data were obtained. Pathology. The saline puncture controls were routinely uninfected upon assay, and healing appeared to be complete in 4 days. In the infected, untreated controls observed during the course of the infection, healing and scar tissue formation were often progressing well in some lesions of kidneys which also had large purulent lesions. In general, obvious visible correlation was not found between titers of viable bacteria and the grossly apparent condition of the kidney, except that (i) kidneys with purulence covering more than half the surface invariably had very high titers, and (ii) kidneys with no visible purulence nearly always had low titers. Gross examination of the kidneys showed conical lesions extending centripetally from the capsule and outer cortex through the medulla to the pelvic sinus. Kidneys were often invaginated and reduced in size around scar tissue. Examination of a number of kidneys at various times after infection showed that the basic lesion that developed from the infection was a focal acute suppurative nephritis which developed into a chronic nephritis with a lymphocytic-plasma cell infiltration (in other words, a chronic infection), and that the end result was the same as the end result of pyelonephritis.
Urolithiasis and cystitis. Infected bladders, with or without stones, were found in less than 0.1 % of several thousand E. coli infections.
In Proteus infections, 3 .2% of females had infected bladders and 26.4% of these (0.84% of all females) had visible stones. In males infected with Proteus, 18.9%-had apparently infected bladders and 76% of these (14.7% of all males) had stones. Bladder stone is predominantly a male disease in humans also (6) ; only about 5 % of bladder stones occur in women, owing to infrequency of vesical neck or urethral obstruction in females (5) . Kidney stones were observed only twice in several thousand rats. The average of the two sexes for the bladder stone parameter is about 7.5% for this organism. By comparison, renal calculi are found in about 5.4% of autopsied persons, but very few of these have been clinically apparent (1) . Rates of admission to hospitals for stones range from about 2 to 20 per 10,000 population per year (3) .
DISCUSSION
Correlation between the amount of renal abscess and numbers of bacteria had been found in mice (8) . The usual finding (2, 4, 7, 9 ) is a lack of correlation. It is plausible to assume that the generation time or rate of metabolism and substrates utilized by the bacteria, or both, might have some relationship to the pathology, and we are currently using labeled bacteria to obtain information about these parameters. A number of biochemical/enzymatic parameters are also being investigated for possible routine incorporation into compound evaluation in this screen to allow the following of correlation with effective therapy. These studies should aid in clarifying the condition(s) for which we are seeking drug products.
We have taken the position that the main function of a primary animal model infection is to uncover potential products or structural leads to potential products. We are unconcerned that efficacy is not necessarily seen with doses comparable to those used clinically; it is enough to produce a convincing effect in a different animal. Meaningful data on the numbers of bacteria per gram of kidney in humans are nonexistent, but we believe that consistent reductive effect on this parameter with a number of clinically effective agents in more than one metanephric mammalian kidney is presumptive evidence of beneficial effect. An excellent dog Escherichia pyelonephritis model, developed by others in these laboratories, is available to us for secondary and tertiary evaluations. We have been able also to produce chronic Proteus infections in adolescent swine by a very simple procedure, and it would appear to be a useful animal for the secondary evaluation of putative potential anti-Proteus genitourinary agents.
This model offers (i) ease of execution, allowing its use as a primary or secondary screen; (ii) clear indication of statistically significant effect with all important tested clinical entities for this use; (iii) "chronic" infections as defined pathologically; (iv) capability of evaluating 180 compounds per month per 900 rats per technician; (v) an infective procedure which, when used without bacteria (saline-puncture control), allows the distinction and determination of those chemical responses which are peculiar to infection as compared with those which are characteristic of trauma in general; and (vi) sufficient temporal repetition and numbers (11,000 rats in 1 year) to give perspective and convincing reproducibility.
The efficient use of reliable models provides a situation in which efficacious compounds may be discovered, and the study of the relevant mechanisms involved could lead to new types of chemotherapeutic agents.
